{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-016916","form_type":"8-K","ticker":"TTRX","cik":"0002023016","company_name":"Turn Therapeutics Inc.","filed_at":"2026-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.017291+00:00","generated_at":"2026-05-16T02:34:46.025345+00:00","sec_items":["7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Turn Therapeutics appoints former CDC Director Dr. Robert Redfield as Senior Advisor for GX-03","bullets":["Dr. Redfield appointed Senior Advisor of Health Policy and Regulatory Affairs, effective immediately.","He will provide strategic guidance on clinical development and regulatory positioning of lead candidate GX-03.","GX-03 is currently in Phase 2 clinical trials for dermatologic inflammatory conditions.","Dr. Redfield served as 18th Director of the CDC (2018-2021) and led federal public health responses.","Turn Therapeutics is a clinical-stage biotech focused on targeted inflammatory and immunology therapies."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-016916","json":"https://secwatch.observer/filing/0001213900-26-016916.json","markdown":"https://secwatch.observer/filing/0001213900-26-016916.md","text":"https://secwatch.observer/filing/0001213900-26-016916.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2023016/000121390026016916/0001213900-26-016916-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2023016/000121390026016916/ea0277212-8k_turn.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:34:46.025345+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}